Measuring and illustrating statistical evidence in a cost-effectiveness analysis

Journal of Health Economics
Jeffrey S Hoch, Jeffrey D Blume

Abstract

Recently, there has been much interest in using the cost-effectiveness acceptability curve (CEAC) to measure the statistical evidence of cost-effectiveness. The CEAC has two well established but fundamentally different interpretations: one frequentist and one Bayesian. As an alternative, we suggest characterizing the statistical evidence about cost-effectiveness using the likelihood function (the key element of both approaches). Its interpretation is neither dependent on the sample space nor on the prior distribution. Moreover, the probability of observing misleading evidence is low and controllable, so this approach is justifiable in the traditional sense of frequentist long-run behaviour. We propose a new graphic for displaying the evidence about cost-effectiveness and explore the strengths of likelihood methods using data from an economic evaluation of a Program in Assertive Community Treatment (PACT).

References

Jun 1, 1990·Hospital & Community Psychiatry·M Olfson
Dec 1, 1988·American Journal of Public Health·S N Goodman, R Royall
Apr 1, 1980·Archives of General Psychiatry·M A Test, L I Stein
Jul 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·B J Burns, A B Santos
Sep 1, 1994·Health Economics·B A van HoutF F Rutten
Jan 1, 1995·Schizophrenia Bulletin·J E Scott, L B Dixon
Nov 21, 1997·Archives of General Psychiatry·A F LehmanL T Postrado
May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A A Stinnett, J Mullahy
May 16, 1998·American Journal of Epidemiology·S N Goodman
Jun 26, 1999·Annals of Internal Medicine·S N Goodman
Oct 26, 1999·The British Journal of Psychiatry : the Journal of Mental Science·A F LehmanR Frank
Jun 16, 2001·Health Economics·A O'Hagan, J W Stevens
Jul 12, 2001·International Journal of Technology Assessment in Health Care·D Coyle, M F Drummond
Sep 3, 2002·Statistics in Medicine·Jeffrey D Blume
Jan 24, 2004·The Journal of the American Association of Gynecologic Laparoscopists·Jeffrey Blume, Jeffrey F Peipert
May 6, 2004·Health Economics·Elisabeth FenwickAndrew Briggs
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Jul 4, 1970·Nature·A W Edwards
Sep 24, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martin E Backhouse
Sep 24, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Scott RamseyShelby Reed
Jan 11, 2007·Statistics in Medicine·Jeffrey D BlumeStephen T McGarvey
Apr 6, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Elisabeth Fenwick, Andrew Briggs
Apr 6, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Bas Groot KoerkampMilton C Weinstein

❮ Previous
Next ❯

Citations

Jul 18, 2012·Cost Effectiveness and Resource Allocation : C/E·Sennen Hounton, David Newlands
May 21, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Dirk MüllerAfschin Gandjour
Apr 8, 2021·Statistical Methods in Medical Research·Andrew J SpiekerNandita Mitra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.